Vaccines and Related Biological Products Advisory Committee – 9/17/2021

November 2, 2021 3:31 pm
Join us for a Vaccines and Related Biological Products Advisory Committee meeting to discuss Pfizer-BioNTech’s supplemental Biologics License Application for administration of a third dose, or “booster” dose, of the COVID-19 vaccine, Comirnaty, in individuals 16 years of age and older. Watch live captions here: https://www.captionedtext.com/client/…
Category: News
About The Author
-
Previous

CDC & FDA Okay Booster Shots For Some Americans | The View
Next

FDA Advisory Panel Unanimously Recommends Moderna Booster Shots Against Covid

Related Videos

Virtual Press Conference: COVID-19 Vaccines for Children 5-11 Years Old – 10/29/2021

Virtual Press Conference: COVID-19 Vaccines for Children 5-11 Years Old – 10/29/2021

FDA committee meets to debate and vote on Covid booster shots for the general public — 9/17/21

FDA committee meets to debate and vote on Covid booster shots for the general public — 9/17/21

2 FDA Experts Raise Doubts About COVID-19 Booster Shots

2 FDA Experts Raise Doubts About COVID-19 Booster Shots

FDA Panel Recommends J&J Booster Shot For Adults 18 And Over

FDA Panel Recommends J&J Booster Shot For Adults 18 And Over

FDACDC Phase3

Top COVID-19 doctors and scientists privately asked the Biden administration to scrap its booster-shot plan, report says

FDACDC Phase6

Tense decision-making as CDC joins FDA in recommending Pfizer booster shot for 65 & up, people at high risk and those with occupational exposure to COVID-19